| Type | Question it answers | Time | Typical use |
|---|---|---|---|
| Systematic review | Does X work, for whom, by how much? | 9–18 months | Policy decisions, guidelines, funding |
| Meta-analysis | What is the pooled effect across studies? | Within a systematic review | When studies are similar enough to combine |
| Scoping review | What has been studied, how, and where are the gaps? | 3–9 months | New or diffuse fields; before a full review |
| Rapid review | What does the evidence say, by next month? | 4–12 weeks | A decision with a deadline |
| Realist synthesis | What works for whom, in what circumstances, and why? | 6–18 months | Complex programmes with mechanisms |
| Qualitative evidence synthesis | How do people experience or explain X? | 6–12 months | Acceptability, implementation, meaning |
| Evidence gap map | Where is the evidence dense and where absent? | 3–6 months | Setting a research agenda |
| Umbrella review | What do the existing reviews say? | 3–6 months | Mature fields with many reviews |
| Bibliometric analysis | Who publishes what, where, citing whom? | 2–8 weeks | Mapping a field, not judging its findings |
| Body | Founded | What it holds |
|---|---|---|
| Cochrane | 1993 | Health reviews; the Handbook is the method reference for every field |
| Campbell Collaboration | 2000 | Education, crime, social welfare and, with 3ie, international development |
| 3ie (International Initiative for Impact Evaluation) | 2008 | Development Evidence Portal: impact evaluations, reviews and gap maps |
| EPPI-Centre, UCL | 1993 | Methods and reviews across social policy; the microfinance review above |
| JBI (Joanna Briggs Institute) | 1996 | Scoping-review guidance and appraisal tools |
| PROSPERO, University of York | 2011 | Prospective register of review protocols |
| Element | Asks | Example: cash transfers and schooling |
|---|---|---|
| Population | Whose outcomes? | Children aged 6–18 in households below a poverty threshold, low- and middle-income countries |
| Intervention | What is being done? | Cash transfer to the household, conditional on school attendance |
| Comparison | Compared with what? | No transfer, or an unconditional transfer of the same value |
| Outcome | Measured how? | Enrolment, attendance, completion, learning (test scores) |
| Dimension | Include | Exclude | Why it matters |
|---|---|---|---|
| Population | Households in LMICs; children 6–18 | High-income countries; adult learners | Transferability of the answer |
| Intervention | Cash conditional on attendance | In-kind transfers, scholarships | Different mechanism, different question |
| Comparison | No transfer; unconditional transfer | Before–after with no comparison group | Cannot separate effect from trend |
| Outcomes | Enrolment, attendance, completion, test scores | Self-reported "benefit" | Comparable measures |
| Design | RCT, RDD, DiD, matched | Cross-sectional correlations | Ability to support a causal claim |
| Time | 2000 onward | Earlier | Programme era; data quality |
| Language | Any, with translation budget | None excluded | English-only excludes Indian-language evaluations |
| Publication | Peer-reviewed and grey | Opinion pieces, news | Grey literature holds most development evaluations |
| Role | Does | Minimum |
|---|---|---|
| Lead reviewer | Owns the question, protocol and write-up | One, with time |
| Second screener and extractor | Independent screening and extraction of every record | One; dual screening is not optional |
| Information specialist | Builds and translates the search across databases | A librarian, even for a day |
| Statistician or methodologist | Meta-analysis, heterogeneity, bias assessment | For any pooled analysis |
| Subject expert | Knows the programmes, the grey literature and the people to email | Advisory |
| Language readers | Screen and extract studies in Hindi, Bangla, Tamil and so on | As the question demands |
| Item | Decision |
|---|---|
| Question | Do economic self-help group programmes improve women's economic, social and political empowerment? |
| Population | Adult women in LMICs; group-based savings or credit programmes |
| Comparison | No programme, or waitlist |
| Outcomes | Economic (income, assets, savings), social (mobility, decision-making), political (participation) |
| Designs | RCT, quasi-experimental with comparison group |
| Search | Nine databases plus 3ie, J-PAL, IPA, NGO sites; no language limit |
| Synthesis | Random-effects meta-analysis by outcome domain; narrative for the rest |
| Source | Covers | Access | Use for |
|---|---|---|---|
| PubMed / MEDLINE | Biomedicine, public health; MeSH vocabulary | Free | Any health outcome |
| Scopus | Multidisciplinary, 1970s onward; strong on Indian journals | Subscription | Broad coverage, citation data |
| Web of Science | Multidisciplinary core journals | Subscription | Citation chasing, bibliometrics |
| EconLit | Economics journals and working papers | Subscription | Development economics |
| ERIC | Education | Free | Schooling outcomes |
| OpenAlex | Everything with a DOI, plus much without | Free, API | Free multidisciplinary search; bibliometrics |
| Google Scholar | Widest net, opaque ranking | Free | Grey literature, citation chasing; not as a sole source |
| 3ie Development Evidence Portal | Impact evaluations and reviews in development | Free | Every development review |
| IDEAS/RePEc, SSRN, NBER | Working papers | Free | Economics before it is published |
| Shodhganga (INFLIBNET) | Indian doctoral theses, full text | Free | Indian evidence nobody else indexes |
| Source | What it holds | Note |
|---|---|---|
| Shodhganga | Full-text doctoral theses from Indian universities, via INFLIBNET | Theses hold primary data on programmes nobody published on |
| Economic and Political Weekly archive | Fifty-plus years of applied Indian social science | Indexed unevenly by Scopus; search directly |
| IndMED / IndMedica | Indian biomedical journals not in MEDLINE | Public-health and nutrition evaluations |
| National Digital Library of India | Aggregated theses, reports, books | Coverage varies; useful for older material |
| NCAER, IGIDR, CDS, ISEC, IEG working papers | Institute series | Search each site; few are indexed |
| Ministry and state evaluation reports | Programme evaluations by DMEO, NITI Aayog, state bodies | PDFs, often undated; record the retrieval date |
| icddr,b (Bangladesh), NIPS and PIDE (Pakistan), CBS Nepal, IPS Sri Lanka | National institutes' evaluations and surveys | Regional coverage that global databases miss |
| Log entry | Example |
|---|---|
| Database | Scopus |
| Date | 2026-09-10 |
| String | TITLE-ABS-KEY(("self-help group*" OR SHG) AND (women OR female) AND (empower* OR "decision-making")) |
| Limits | 2000–2026; no language limit |
| Records | 1,412 |
| Exported as | scopus_shg_20260910.ris |
| Tool | Cost | Does | Limit |
|---|---|---|---|
| Rayyan | Free tier | Blinded dual screening, conflict resolution, deduplication, keyword highlighting | Full-text management is basic |
| Covidence | Paid; free for Cochrane authors | Screening, extraction forms, risk of bias, PRISMA numbers | Cost for a student team |
| EPPI-Reviewer | Paid; some free access | Coding, screening, machine-learning priority screening | Learning curve |
| ASReview | Free, open source | Active-learning screening: ranks records by predicted relevance | A stopping rule must be chosen and reported |
| Zotero + a spreadsheet | Free | Everything, by hand | Blinding and conflicts are manual |
| Stage | Count | Where it goes |
|---|---|---|
| Records identified from databases | 4,212 | Box 1, by database |
| Records from other sources | 318 | Registers, websites, citation chasing, separately |
| Duplicates removed | 1,140 | Before screening |
| Records screened (title/abstract) | 3,390 | |
| Records excluded | 3,102 | |
| Reports sought for retrieval | 288 | |
| Reports not retrieved | 9 | Named in appendix |
| Reports assessed for eligibility | 279 | |
| Reports excluded, with reasons | 241 | Counts per reason |
| Studies included | 38 (in 41 reports) | Studies, not papers |
| Group | Items | Why it matters later |
|---|---|---|
| Identification | Study ID, all reports of it, year, country, funder, registration number | Linking reports to studies; funding as a bias signal |
| Setting | Rural/urban, state or district, baseline poverty or prevalence, delivery agency | Applicability to your context; subgroup analysis |
| Population | Eligibility, age, sex, numbers randomised and analysed per arm | Attrition; denominators for effect sizes |
| Intervention | Components, intensity, duration, who delivered, cost if reported, comparator in the same detail | The comparator explains half of all heterogeneity |
| Design | RCT/cluster/quasi-experimental method, unit of assignment, clustering handled? | Cluster trials analysed as individual data have false precision |
| Outcomes | Every outcome and timepoint pre-specified in the protocol, with definition, instrument and who measured it | Selective reporting; measurement bias |
| Results | Means and SDs, or counts and denominators, or coefficients with SEs, per arm and timepoint | Effect sizes; never extract only the p-value |
| Analysis | Adjusted vs unadjusted, covariates, intention-to-treat vs per-protocol | Which estimate to pool |
| Authors' claims | Their stated conclusion, verbatim | For the discrepancy check between claim and data |
| Paper reports | You need | Conversion |
|---|---|---|
| Mean, SE, n per arm | SD | SD = SE × √n |
| Mean and 95% CI | SD | SD = √n × (upper − lower) / 3.92 |
| Median and IQR | Mean and SD | Approximate (Wan et al. 2014, BMC Med Res Methodol 14:135); note the approximation |
| Regression coefficient and SE | Mean difference | Use directly if unadjusted comparison; adjusted estimates pooled separately |
| t-statistic and n | SMD | d = t × √(1/n1 + 1/n2) |
| Percentages and n per arm | Risk ratio, odds ratio | Rebuild the 2×2 table; take logs before pooling |
| 'Significant at 5%' only | Nothing usable | Email the authors; otherwise record as not extractable |
| Domain | Question it asks | A development example |
|---|---|---|
| 1. Randomisation process | Was the sequence random and allocation concealed? Do baselines suggest a problem? | Lottery in public with sealed lists: low. NGO staff choosing 'eligible' villages after the list: high |
| 2. Deviations from intended interventions | Did participants or staff know the assignment, and did that change what they did? Was the analysis appropriate? | Control villages receiving a similar scheme from another donor mid-trial |
| 3. Missing outcome data | How much attrition, and was it related to the outcome? | 30% attrition in a migration-prone district, higher in the control arm |
| 4. Measurement of the outcome | Was the assessor blind? Could knowing the assignment change the measurement? | Enumerators from the implementing NGO measuring self-reported income |
| 5. Selection of the reported result | Was there a pre-analysis plan, and does the paper report what it planned? | Twelve outcomes measured, three reported, no registration |
| Domain | Judgement hinges on |
|---|---|
| Confounding | Were the important confounders (listed in advance by the review team) measured and controlled? Time-varying confounding? |
| Selection of participants | Did entry into the study depend on characteristics observed after the intervention started? |
| Classification of interventions | Was exposure status defined clearly and recorded without knowledge of outcome? |
| Deviations from intended interventions | Co-interventions, contamination, switching |
| Missing data | Attrition, and whether it differs by arm and outcome |
| Measurement of outcomes | Assessor knowledge of exposure; comparable methods across groups |
| Selection of the reported result | Multiple analyses, subgroups, outcomes, with no plan |
| Design | Tool | Notes |
|---|---|---|
| Cohort, case-control | Newcastle-Ottawa Scale; ROBINS-I | NOS is widely used and has poor inter-rater reliability (Hartling et al. 2013, J Clin Epidemiol 66:982); prefer ROBINS-I where the question is causal |
| Cross-sectional prevalence | JBI critical appraisal checklist; Hoy et al. 2012 tool | Sampling frame, response rate and case definition are the items that matter |
| Diagnostic accuracy | QUADAS-2 | Four domains: patient selection, index test, reference standard, flow and timing |
| Qualitative | CASP qualitative checklist; JBI qualitative tool | Appraises credibility and reflexivity, not bias; feeds GRADE-CERQual |
| Mixed methods | MMAT (Hong et al. 2018) | One tool across designs, five items each, no summed score |
| Economic evaluations | CHEERS 2022 (reporting); Drummond checklist | Costing perspective and discount rate are the usual gaps |
| Modelling and simulation | No standard tool | Judge against ISPOR good-practice guidance; say that no validated tool exists |
| Outcome type | Measure | When to use it | Watch for |
|---|---|---|---|
| Continuous, same scale | Mean difference (MD) | All studies report the outcome in the same units: rupees per month, cm, test score on one instrument | Units and scaling (monthly vs annual) must match exactly |
| Continuous, different scales | Standardised mean difference (Hedges' g) | Studies use different tests or indices for the same construct | Sensitive to the SD used; heterogeneous populations widen SDs and shrink g |
| Binary | Risk ratio (RR) | Most interpretable for events such as enrolment, immunisation, default | Cannot be used when the control event rate is zero |
| Binary | Odds ratio (OR) | Case-control designs; logistic regressions | Overstates RR when events are common; often misread as RR |
| Binary | Risk difference (RD) | Absolute effect for policy: percentage points of coverage gained | Varies with baseline rate, so usually more heterogeneous than RR |
| Rate | Rate ratio, hazard ratio | Events per person-time; survival | Hazard ratios need the estimate and CI from the paper; rarely derivable |
| Regression coefficient | Partial correlation, elasticity, or MD from coefficient | Economics literatures where every study is a regression | Comparability across specifications; see Stanley and Doucouliagos 2012 |
| Study | Effect (SMD) | SE | Weight w = 1/SE² | Share | w × effect |
|---|---|---|---|---|---|
| A | 0.20 | 0.10 | 100 | 19.0% | 20.00 |
| B | 0.35 | 0.20 | 25 | 4.8% | 8.75 |
| C | 0.05 | 0.05 | 400 | 76.2% | 20.00 |
| Sum | 525 | 100% | 48.75 |
| Statistic | Formula | Our example | Reads as |
|---|---|---|---|
| Cochran's Q | Σ wi(θi − θ̂)² | 3.54 on 2 df (p = 0.17) | A test with low power when k is small; do not rely on its p-value |
| I² | (Q − df) / Q | 43% | Share of observed variation beyond chance; a proportion, not an amount |
| τ² | (Q − df) / C, C = Σw − Σw²/Σw | 0.0077 (τ = 0.088) | Between-study variance in effect-size units; the amount |
| Prediction interval | θ̂ ± tk−2 √(τ² + SE²) | Wide, with k = 3 | Where a new study's effect would likely fall |
| Study | Effect | SE² + τ² | Weight w* | Share | Fixed share |
|---|---|---|---|---|---|
| A | 0.20 | 0.0100 + 0.0077 | 56.6 | 32.2% | 19.0% |
| B | 0.35 | 0.0400 + 0.0077 | 21.0 | 11.9% | 4.8% |
| C | 0.05 | 0.0025 + 0.0077 | 98.2 | 55.9% | 76.2% |
| Pooled | 0.134 | SE 0.075 | 175.8 | FE: 0.093 |
| Decision | Alternative to test | Report as |
|---|---|---|
| Random vs fixed effect | The other model | Both estimates, one sentence on the difference |
| Inclusion of high-risk studies | Restrict to low risk | Pooled effect with and without; the difference is a finding |
| Imputed SDs or ICCs | Exclude imputed studies; halve and double the ICC | Range of pooled estimates |
| One influential study | Leave-one-out: re-run k times dropping each study | Plot of k estimates; name any study whose removal changes the conclusion |
| Effect measure | RR instead of OR; MD instead of SMD where possible | Direction and significance under each |
| Outliers | Exclude studies whose CI does not overlap the pooled CI | With and without, plus a reason the outlier differs |
| Publication bias | Trim-and-fill; PET-PEESE; selection model | Adjusted estimate labelled as a sensitivity result |
| Tool | Cost | Best for | Limits |
|---|---|---|---|
| R: metafor | Free | Everything: all models, meta-regression, RVE, plots; the reference implementation (Viechtbauer, J Stat Softw 2010, 36(3)) | Code, not menus; a learning curve of a few days |
| R: meta | Free | Quick pooled analyses and publication-quality forest plots with one function call | Fewer model options than metafor |
| RevMan Web | Free | Cochrane-format reviews, risk-of-bias tables, summary-of-findings tables | Limited models; no meta-regression |
| Jamovi with the MAJOR module | Free | Point-and-click meta-analysis for a first course; metafor underneath | Fewer diagnostics; export is limited |
| JASP | Free | Classical and Bayesian meta-analysis with menus | Newer, fewer worked examples online |
| Stata meta suite | Licence | Economists already in Stata; meta-regression, funnel tests, forest plots | Cost; RVE needs the user-written robumeta |
| Comprehensive Meta-Analysis | Licence | Effect-size conversion from almost any reported statistic | Cost; closed |
| Method | What it does | Source | Use when |
|---|---|---|---|
| Thematic synthesis | Codes findings line by line, builds descriptive themes, then analytical themes that go beyond the studies | Thomas and Harden 2008, BMC Med Res Methodol 8:45 | The question is about experience, acceptability, barriers |
| Framework synthesis | Starts from an a priori framework (a theory of change, a policy's own logic) and codes into it, adding themes that do not fit | Carroll et al. 2011; Booth and Carroll 2015 | A commissioner has a framework and wants evidence mapped to it |
| Meta-ethnography | Translates concepts across studies (reciprocal, refutational), then a line of argument | Noblit and Hare 1988; eMERGe reporting guidance 2019 | Interpretive depth on a small set of rich studies |
| Realist synthesis | Asks what works for whom in what circumstances; builds context-mechanism-outcome configurations | Pawson et al. 2005; RAMESES standards, Wong et al. 2013, BMC Medicine 11:21 | Complex interventions whose effect depends on how people respond |
| Meta-aggregation | Pools findings into categories and synthesised statements with recommendations | JBI | Practice guidance in health |
| Domain | Downgrade when | A development example |
|---|---|---|
| Risk of bias | Most of the weight comes from studies at high risk or with some concerns, and a sensitivity analysis moves the estimate | Three of five trials unregistered with outcomes chosen after the fact |
| Inconsistency | Effects point in different directions, intervals barely overlap, I² is high and subgroups do not explain it | Enrolment effects of 0.02 and 0.25 across states with no moderator found |
| Indirectness | The studies' population, intervention, comparator or outcome differ from the review question | Question is about Bangladesh; evidence is from Mexico and Brazil; outcome is attendance, not learning |
| Imprecision | The confidence interval includes both a worthwhile benefit and no effect (or harm); total sample below the optimal information size | Pooled RR 1.15 (0.92 to 1.44) from 600 households |
| Publication bias | Small-study effects, or many registered trials with no results, or a field where nulls are known not to be published | Funnel asymmetry across 14 microenterprise studies; 6 registered trials unreported |
| Outcome | Studies (participants) | Relative effect (95% CI) | Absolute effect | Certainty | Comment |
|---|---|---|---|---|---|
| School enrolment, 1 year | 7 RCTs (41,200 children) | RR 1.08 (1.04 to 1.12) | 6 more per 100 enrolled (3 to 9 more), from 75 per 100 | Moderate | Downgraded for inconsistency |
| Test scores, 2 years | 4 RCTs (18,500) | SMD 0.04 (−0.03 to 0.11) | Roughly 1 percentile point | Low | Downgraded for imprecision and indirectness |
| Child labour | 3 RCTs, 2 quasi (9,800) | RR 0.91 (0.80 to 1.03) | 4 fewer per 100 (9 fewer to 1 more) | Low | Downgraded for risk of bias, imprecision |
| Household consumption | 9 studies (52,000) | MD +7% (4 to 10) | About Rs 420 per month at the baseline mean | High | Consistent, precise, direct |
| Section | Items | What reviewers check |
|---|---|---|
| Title, abstract | 1–2 | 'Systematic review' in the title; the 12-item abstract checklist |
| Introduction | 3–4 | Rationale and explicit objectives |
| Methods | 5–15 | Eligibility, sources, full search strategy, selection and extraction processes, risk of bias, effect measures, synthesis methods, certainty |
| Results | 16–22 | Flow diagram, study characteristics, risk of bias per study, individual and synthesised results, certainty |
| Discussion | 23 | Interpretation, limitations of evidence and of the review, implications |
| Other | 24–27 | Registration and protocol, support, competing interests, availability of data and code |
| Outlet | Scope | Expectations |
|---|---|---|
| Campbell Systematic Reviews | Social welfare, education, crime, international development, methods; open access, no fee | Registered title and protocol first; full Campbell and GRADE standards; editorial and methods review before acceptance |
| Cochrane Database of Systematic Reviews | Health, including nutrition, WASH, maternal and child health | Cochrane review group registration; RevMan format; MECIR conduct and reporting standards |
| 3ie systematic review series | Development effectiveness; commissioned and open access | 3ie protocol approval; quasi-experimental risk-of-bias tool; evidence gap map alongside |
| Journal of Development Effectiveness | Impact evaluation and synthesis in development | PRISMA; interest in methods and policy relevance |
| World Development, Journal of Development Economics | General development; reviews accepted selectively | Contribution beyond summary; meta-regression rather than description |
| Systematic Reviews (BMC), Research Synthesis Methods | Protocols, methods, reviews across fields | Open access with article fee; waivers for low- and middle-income authors |
| Indian outlets: EPW, Indian Journal of Medical Research, IJCM | Policy audiences and health; systematic reviews accepted | Shorter formats; PRISMA still expected; check the journal's indexing before submission |
| Technique | Unit | Question | Output |
|---|---|---|---|
| Publication and citation counts | Authors, institutions, countries, journals, years | Who produces the field, and where is it published? | Ranked tables; annual output curve |
| Citation analysis | Documents | Which works are the field's foundations? | Most-cited list, citation half-life |
| Co-citation | Pairs of documents cited together | What is the intellectual structure? Documents co-cited often belong to one school | Clusters of foundational works (Small 1973) |
| Bibliographic coupling | Pairs of documents sharing references | What is the current research front? Papers citing the same sources work on the same problem | Clusters of recent papers (Kessler 1963) |
| Co-authorship | Authors, institutions, countries | Who collaborates with whom; where are the isolated groups? | Collaboration network |
| Co-word (keyword co-occurrence) | Keywords or title terms | What are the topics and how do they connect and shift over time? | Thematic map; overlay by year |
| Source | Access | Coverage | Export |
|---|---|---|---|
| Scopus (Elsevier) | Subscription; many Indian universities via consortia | Over 27,000 active titles; curated; weaker on regional and non-English journals | CSV, RIS, BibTeX with references; 2,000 records at a time |
| Web of Science (Clarivate) | Subscription | Narrower and older; the source of the Journal Impact Factor | Tab-delimited with cited references; 500 or 1,000 at a time |
| OpenAlex | Free, open API and web interface; launched 2022 as the successor to Microsoft Academic Graph | Broadest: over 250 million works, but with noisier metadata | CSV, JSON via API; no limit in practice |
| Dimensions | Free basic search; paid for full | Wide, includes grants and policy documents | Limited in the free tier |
| Lens.org | Free for individuals | Scholarly works plus patents; good for applied fields | CSV, RIS |
| Google Scholar | Free | Widest, including theses and reports; no quality control | No export; Publish or Perish scrapes it in small batches |
| Shodhganga (INFLIBNET) | Free | Indian theses in full text | No structured export; useful as a source, not a dataset |
| Tool | Cost | Strength | Limit |
|---|---|---|---|
| VOSviewer | Free (Leiden); van Eck and Waltman, Scientometrics 2010, 84:523 | Network maps: co-authorship, co-citation, coupling, co-word; overlay and density views; reads Scopus, WoS, OpenAlex, Lens | Maps only; counts and trends need another tool; thesaurus by text file |
| Bibliometrix and biblioshiny (R) | Free; Aria and Cuccurullo, Journal of Informetrics 2017, 11:959 | Full workflow in one package: import, descriptives, laws, networks, thematic maps, a point-and-click interface | R installation; large networks are slow in the browser interface |
| CiteSpace | Free for academic use; Chen, JASIST 2006, 57:359 | Bursts and turning points over time; timeline views | Java, dated interface; WoS-centred |
| Publish or Perish (Harzing) | Free | Author and journal metrics from Google Scholar, Scopus, OpenAlex, Crossref | Small batches; no networks |
| Gephi | Free | Any network, with full layout and statistics control | You build the network file yourself |
| Python: pyalex, pybibx | Free | Scripted pulls from OpenAlex; reproducible pipelines | Code required |
| Indicator | Definition | Use | Misuse |
|---|---|---|---|
| h-index | h papers with at least h citations each (Hirsch, PNAS 2005, 102:16569) | A rough summary of an author's output and uptake | Comparing across fields or career stages; it only rises, and it rewards volume |
| Journal Impact Factor | Citations in year t to items from t−1 and t−2, divided by citable items | Comparing journals within one field | Judging an article or an author by its journal; skewed by a few highly cited papers |
| CiteScore (Scopus) | Four-year window, all document types | As above, wider coverage | As above |
| Field-weighted citation impact | Citations relative to the world average for the same field, year and document type | Cross-field comparison at institutional scale | Small numbers; a single paper's FWCI is noise |
| Altmetrics | Mentions in policy documents, news, social media | Tracing policy uptake of development research | Treating attention as quality |
| Step | Decision | Illustrative result |
|---|---|---|
| Query | TITLE-ABS-KEY("cash transfer*" AND (poverty OR welfare OR "social protection")), 2000–2025, articles and reviews | 3,140 Scopus records |
| Clean | Merge 212 author variants, 96 institution variants, keyword thesaurus of 140 lines | 3,088 records after de-duplication |
| Output | Annual curve | Under 20 a year to 2005; about 300 a year by 2022 |
| Producers | Countries by corresponding author | USA, UK, then Brazil, Mexico, South Africa; India seventh, Bangladesh and Pakistan in the top twenty |
| Journals | Bradford core | World Development, Journal of Development Effectiveness, Social Science & Medicine, Journal of Development Economics |
| Co-citation | Documents, minimum 20 citations | Clusters around Progresa evaluations, unconditional-transfer trials, and health and nutrition outcomes |
| Co-word overlay | Author keywords, minimum 10 occurrences | Recent yellow: 'COVID-19', 'digital payments', 'universal basic income'; older blue: 'conditionality', 'Progresa' |
| Stage | Tool | Notes |
|---|---|---|
| Protocol | PROSPERO or OSF Registries; PRISMA-P checklist | OSF accepts any discipline; PROSPERO is health-focused and slow to register |
| Search | PubMed, Google Scholar, OpenAlex, RePEc/IDEAS, 3ie repository, Campbell library; Scopus where the institution has it | Save every strategy as run, with date and count |
| Reference management | Zotero, with the Better BibTeX plugin | Free, open; de-duplication and full-text retrieval built in |
| Screening | Rayyan (free tier); or a shared Zotero library with tags | Rayyan blinds screeners to each other and logs conflicts |
| Extraction | Google Sheets or LibreOffice Calc from a piloted template; SRDR+ (AHRQ, free) | One row per study; a 'source page' column for every number |
| Risk of bias | RoB 2 and ROBINS-I Excel tools from riskofbias.info; robvis for figures | Two assessors; keep the signalling-question answers |
| Analysis | R with metafor and meta; Jamovi with MAJOR for menus | Script and data in a public repository |
| Certainty | GRADEpro GDT (free for non-commercial use) | Produces the summary-of-findings table |
| Bibliometrics | OpenAlex export, biblioshiny, VOSviewer | All offline after export |
| Reporting | PRISMA 2020 checklist and flow diagram generator (Haddaway et al. 2022, R package and web app) | Fill the checklist against your own draft before submission |
| Phase | Weeks (typical) | People | Output |
|---|---|---|---|
| Question, scoping searches, protocol | 4–8 | Lead, methodologist, subject expert, librarian | Registered protocol |
| Search and de-duplication | 2–3 | Librarian or trained searcher | Search log; record set |
| Title and abstract screening | 3–6 | Two screeners | Calibrated screening; conflict log |
| Full-text screening | 3–5 | Two screeners | Excluded-with-reasons list |
| Extraction and appraisal | 6–10 | Two extractors, two assessors | Extraction sheet; risk-of-bias table |
| Synthesis and GRADE | 4–8 | Statistician or methodologist, lead | Analyses; summary-of-findings table |
| Writing, PRISMA, submission | 4–6 | Lead, all authors | Manuscript with checklist and appendices |
| Total | 26–46 | Four to six people, part time | Consistent with Borah et al.'s median of 67 weeks elapsed |
| Pitfall | What it looks like | Prevention |
|---|---|---|
| No protocol | Criteria change as papers arrive | Register before searching |
| One database | 'We searched Google Scholar' | Three or more, plus grey literature, plus citation chasing |
| Single screener | 'Studies were selected by the first author' | Two, with a conflict log |
| Pooling different comparators | Cash vs nothing pooled with cash vs in-kind | Comparator as an eligibility criterion and a subgroup |
| Appraisal ignored | A traffic-light figure and then equal weights | Sensitivity analysis by risk of bias, in the abstract |
| Counting p-values | 'Seven of ten studies found significant effects' | Direction counts or effect sizes |
| I² as a verdict | 'Heterogeneity was high (I² = 82%), so results should be interpreted with caution' | τ², a prediction interval, and pre-specified moderators |
| Twelve estimates from one paper | k = 60 from 14 studies with no adjustment | One per study, or RVE |
| Funnel plot with six studies | 'No evidence of publication bias' | Do not test below ten; search the file drawer instead |
| No certainty rating | Results reported as if all equally reliable | GRADE per outcome |
| Applicability unaddressed | Evidence from Latin America applied to Nepal without comment | A named paragraph on transfer |
| Bibliometrics as evidence | 'The most-cited interventions are…' | Keep the two products apart |
| Resource | What it is | Access |
|---|---|---|
| Cochrane Handbook for Systematic Reviews of Interventions, version 6.4 (2023) | The reference for every step, from question to GRADE; chapters 5, 6, 8, 10 and 13 are the core | Free online at training.cochrane.org/handbook |
| Gough, Oliver and Thomas, An Introduction to Systematic Reviews, 2nd ed. (Sage, 2017) | The social-science and mixed-methods treatment, from the EPPI-Centre | Book |
| Petticrew and Roberts, Systematic Reviews in the Social Sciences (Blackwell, 2006) | Still the clearest account of why the method transfers beyond medicine | Book |
| Borenstein, Hedges, Higgins and Rothstein, Introduction to Meta-Analysis, 2nd ed. (Wiley, 2021) | Meta-analysis from first principles with worked arithmetic | Book |
| Stanley and Doucouliagos, Meta-Regression Analysis in Economics and Business (Routledge, 2012) | The economics approach: FAT-PET, publication bias, meta-regression | Book |
| Campbell Collaboration and 3ie methods guides | Standards and templates for development reviews; the quasi-experimental risk-of-bias tool | Free at campbellcollaboration.org and 3ieimpact.org |
| Donthu et al. 2021, Journal of Business Research 133:285 | Guidelines for a bibliometric analysis | Journal article |
| Cochrane Interactive Learning; Campbell's online course | Structured courses with exercises | Cochrane's is paid, with free access in some low- and middle-income countries; Campbell's is free |
| ImpactMojo | Survey Design 101, Impact Evaluation 101 and Research Methods 101 in this series cover the primary studies these reviews synthesise | impactmojo.in/101-courses/ |